Screening for multidrug-resistant organism: clinical benefit or unquestioned routine

Alex Soriano, Marta Ulldemolins, Cristina Pitart, Pedro Castro, Mateu Espasa, Josep Mensa

Open source

DOI
10.1097/qco.0000000000001248
Published
2026-10-09
Container
Current Opinion in Infectious Diseases
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/qco.0000000000001248,
  title = {Screening for multidrug-resistant organism: clinical benefit or unquestioned routine},
  author = {Alex Soriano and Marta Ulldemolins and Cristina Pitart and Pedro Castro and Mateu Espasa and Josep Mensa},
  year = {2026},
  journal = {Current Opinion in Infectious Diseases},
  doi = {10.1097/qco.0000000000001248},
  url = {https://doi.org/10.1097/qco.0000000000001248}
}

RIS

TY  - JOUR
TI  - Screening for multidrug-resistant organism: clinical benefit or unquestioned routine
AU  - Alex Soriano
AU  - Marta Ulldemolins
AU  - Cristina Pitart
AU  - Pedro Castro
AU  - Mateu Espasa
AU  - Josep Mensa
PY  - 2026
JO  - Current Opinion in Infectious Diseases
DO  - 10.1097/qco.0000000000001248
UR  - https://doi.org/10.1097/qco.0000000000001248
ER  - 

APA

Soriano, A., Ulldemolins, M., Pitart, C., Castro, P., Espasa, M., & Mensa, J. (2026). Screening for multidrug-resistant organism: clinical benefit or unquestioned routine. Current Opinion in Infectious Diseases. https://doi.org/10.1097/qco.0000000000001248

Source records